{"id":1826,"date":"2024-04-15T06:57:52","date_gmt":"2024-04-15T13:57:52","guid":{"rendered":"http:\/\/www.fcihr.ca\/prize\/?page_id=1826"},"modified":"2024-04-22T06:45:41","modified_gmt":"2024-04-22T13:45:41","slug":"dr-gordon-guyatt-2024-friesen-prize","status":"publish","type":"page","link":"https:\/\/www.fcihr.ca\/prize\/dr-gordon-guyatt-2024-friesen-prize","title":{"rendered":"Dr. Gordon Guyatt, 2024 Friesen Prize"},"content":{"rendered":"

\"PDF\" <\/a>Click here to Download Brief Bio – Dr. Gordon Guyatt<\/a><\/p>\n

\"\"<\/a><\/p>\n

CONGRATULATIONS,
\nDR. GORDON GUYATT<\/span><\/span><\/strong><\/p>\n

Friends of CIHR is pleased to announce that Dr. Gordon Guyatt, MSc, MD, FRCP(C), OC, Distinguished University Professor at McMaster University\u2019s Department of Health Research Methods, Evidence, and Impact is the recipient of the 2024 Henry G. Friesen International Prize in Health Research.<\/strong><\/p>\n

Toronto \u2013 April 15, 2024 \u2013 Dr. Gordon Guyatt is an academic clinical investigator and educator. In 1990, he coined the term “evidence-based medicine” (EBM) to describe a new approach to medical education and practice. Since then, he has been a leading figure in providing educational resources for EBM, a leading innovator in EBM research methods, and made major contributions to clinical trials that have improved patient care.<\/p>\n

Dr. Guyatt received his MD from McMaster University in 1977, completed residency training in internal medicine in Toronto and McMaster in 1982 at which time he joined the then Department of Clinical Epidemiology and Biostatistics and the Department of Medicine, becoming a Distinguished McMaster Professor in 2010.<\/p>\n

In 1990 Dr. Guyatt became the Director of the Internal Medicine residency training and implemented a training program that established EBM as a new way of teaching and practicing medicine. Dr. Guyatt subsequently led the “Evidence-based Medicine Working Group” in describing the approach to teaching and practice he was pioneering and led a series of over 30 “Users’ Guides to the Medical Literature” published in JAMA, a series that has provided the underpinning of all subsequent expositions of evidence-based practice.<\/p>\n

Dr. Guyatt has made major contributions in a number of areas of clinical research. In health status measurement, his pioneering work includes articulation of the concepts of responsiveness and interpretability, and the development of a number of widely used instruments for measuring health-related quality of life.<\/p>\n

Dr. Guyatt has played a major role in the planning and conduct of a large number of randomized control trials of a wide variety of health interventions. He has made major contributions to clinical trial methodology beyond quality of life measurement, including single-subject randomized trials, trials stopped early for benefit, and the use of composite endpoints.<\/p>\n

Dr. Guyatt was one of the first to suggest methodological standards for the conduct of systematic reviews and meta-analyses, and has continued to make major contributions in this area, including seminal work in the conduct and interpretation of subgroup analyses in both individual trials and systematic reviews. He was instrumental in creating the enormously influential GRADE approach to rating certainty of evidence in systematic reviews and moving from evidence to recommendations, an approach that has been adopted in over 110 organizations worldwide.<\/p>\n

Dr. Guyatt has published over 1,500 peer-reviewed articles that have been cited over 200,000 times, establishing him as one of world\u2019s 20 most cited living scientists. His work has been recognized by his appointment as an Officer of the Order of Canada, a Canadian Institute of Health Research Researcher of the Year, a member of the Canadian Medical Hall of Fame, and a recipient of the Einstein Foundation Award for promoting the quality of medical research.<\/p>\n

The Henry G. Friesen International Prize in Health Research, established in 2005 by the Friends of Canadian Institutes of Health Research (FCIHR), recognizes exceptional innovation by a visionary health leader of international stature. The $35,000 Friesen Prize is awarded annually. Dr. Gordon Guyatt will deliver public talks in 2024 in conjunction with the Friesen Prize Program. For further information on Friends of CIHR and the Friesen International Prize, please visit: www.fcihr.ca or contact: Cristina S. Castellvi. Tel. #: (416) 978-6759. Email: FriendsofCIHR@gmail.com<\/a><\/p>\n

\n

\"\"<\/a><\/p>\n

Les Amis des IRSC sont heureux d\u2019annoncer que le Dr Gordon Guyatt, MSc, MD, FRCP(C), OC, professeur \u00e9m\u00e9rite au D\u00e9partement des m\u00e9thodes, des donn\u00e9es probantes et de l\u2019impact de la recherche en sant\u00e9 de l\u2019Universit\u00e9 McMaster, est le laur\u00e9at du Prix international Henry G. Friesen de la recherche en sant\u00e9 2024.<\/strong><\/p>\n

Le Dr Gordon Guyatt est chercheur clinicien universitaire et \u00e9ducateur. En 1990, il a cr\u00e9\u00e9 le terme \u00ab m\u00e9decine fond\u00e9e sur des preuves \u00bb (EBM) pour d\u00e9crire une nouvelle conception de l\u2019enseignement et de la pratique m\u00e9dicale. Depuis, il est une figure de proue en apport de ressources \u00e9ducatives pour l\u2019EBM et un innovateur de premier plan dans les m\u00e9thodes de recherche sur l\u2019EBM, et il a dot\u00e9 les essais cliniques de pr\u00e9cieux ajouts qui ont am\u00e9lior\u00e9 les soins aux patients.<\/p>\n

Le Dr Guyatt s\u2019est vu d\u00e9cerner un doctorat en m\u00e9decine de l\u2019Universit\u00e9 McMaster en 1977 et il a fait sa r\u00e9sidence en m\u00e9decine interne \u00e0 Toronto et \u00e0 l\u2019Universit\u00e9 McMaster en 1982, ann\u00e9e de son arriv\u00e9e au D\u00e9partement d\u2019\u00e9pid\u00e9miologie clinique et de biostatistique et au D\u00e9partement de m\u00e9decine, devenant professeur \u00e9m\u00e9rite de l\u2019Universit\u00e9 McMaster en 2010.<\/p>\n

En 1990, le Dr Guyatt devient directeur de la r\u00e9sidence en m\u00e9decine interne et adopte un programme de formation qui fera de l\u2019EBM une nouvelle fa\u00e7on d\u2019enseigner et de pratiquer la m\u00e9decine. Par la suite, il dirigera le \u00ab Groupe de travail sur la m\u00e9decine fond\u00e9e sur des donn\u00e9es probantes \u00bb en d\u00e9crivant l\u2019approche de l\u2019enseignement et de la pratique dont il sera le pionnier. Il dirigera en outre une s\u00e9rie de plus de 30 \u00ab Guides d\u2019utilisation d\u2019ouvrages m\u00e9dicaux \u00bb, publi\u00e9s dans la revue JAMA, qui sous-tendront tous les expos\u00e9s ult\u00e9rieurs de la pratique fond\u00e9e sur des donn\u00e9es probantes.<\/p>\n

Le Dr Guyatt a fait des contributions marquantes pour divers secteurs de recherche clinique. Dans le domaine de la mesure de l\u2019\u00e9tat de sant\u00e9, ses travaux pr\u00e9curseurs comprennent l\u2019articulation des concepts de r\u00e9activit\u00e9 et d\u2019interpr\u00e9tabilit\u00e9 et la cr\u00e9ation de plusieurs instruments largement utilis\u00e9s pour mesurer la qualit\u00e9 de vie li\u00e9e \u00e0 la sant\u00e9.<\/p>\n

Le Dr Guyatt jouera un r\u00f4le cl\u00e9 dans la planification et la r\u00e9alisation d\u2019un grand nombre d\u2019essais contr\u00f4l\u00e9s al\u00e9atoires portant sur une vaste gamme d\u2019interventions en sant\u00e9. On lui doit des apports de premier plan \u00e0 la m\u00e9thodologie des essais cliniques outre la mesure de la qualit\u00e9 de vie, y compris des essais al\u00e9atoires sur un seul sujet, des essais conclus pr\u00e9matur\u00e9ment pour en tirer profit et l\u2019utilisation de crit\u00e8res d\u2019\u00e9valuation composites.<\/p>\n

Le Dr Guyatt sera l\u2019un des premiers \u00e0 proposer des normes m\u00e9thodologiques pour la r\u00e9alisation d\u2019examens syst\u00e9matiques et de m\u00e9ta-analyses, y ajoutant ensuite des contributions majeures, dont des travaux pr\u00e9curseurs en conduite et interpr\u00e9tation d\u2019analyses de sous-groupes \u00e0 la fois dans les essais individuels et les revues syst\u00e9matiques. Il aura un r\u00f4le d\u00e9terminant pour ce qui sera de cr\u00e9er l\u2019approche GRADE, dont l\u2019influence sera marquante en \u00e9valuation de la certitude des donn\u00e9es probantes dans les revues syst\u00e9matiques et dans le passage des donn\u00e9es probantes aux recommandations, fa\u00e7on de faire qu\u2019adopteront plus de 110 organisations \u00e0 travers le monde.<\/p>\n

Le Dr Guyatt a publi\u00e9 plus de 1 500 articles \u00e9valu\u00e9s par des pairs et cit\u00e9s \u00e0 plus de 200 000 reprises, d\u2019o\u00f9 son rang parmi les 20 scientifiques vivants les plus cit\u00e9s au monde. Son travail a \u00e9t\u00e9 reconnu par sa nomination \u00e0 titre d\u2019Officier de l\u2019Ordre du Canada, de chercheur de l\u2019ann\u00e9e des Instituts de recherche en sant\u00e9 du Canada, de membre du Temple de la renomm\u00e9e m\u00e9dicale canadienne et de r\u00e9cipiendaire du prix de la Fondation Einstein pour la promotion de la qualit\u00e9 de la recherche m\u00e9dicale.<\/p>\n

Le Prix international Henry G. Friesen de la recherche en sant\u00e9, cr\u00e9\u00e9 en 2005 par les Amis des Instituts de recherche en sant\u00e9 du Canada (IRSC), reconna\u00eet l\u2019innovation exceptionnelle d\u2019un chef de file visionnaire de la sant\u00e9 d\u2019envergure internationale. Ce prix, d\u2019une valeur de 35 000 $, est d\u00e9cern\u00e9 chaque ann\u00e9e. Le Dr Gordon Guyatt prononcera des conf\u00e9rences publiques en 2024 dans le cadre du programme du prix Friesen. Pour de plus amples renseignements sur les Amis des IRSC et le Prix international Friesen, veuillez consulter le www.fcihr.ca ou communiquer avec : Cristina S. Castellvi. T\u00e9l. # : 416-978-6759<\/p>\n

\n

Congratulations to the distinguished Gordon Guyatt (@GuyattGH<\/a>) on being awarded the prestigious Henry G. Friesen International Prize in Health Research. @HEI_mcmaster<\/a> @friendsofcihr<\/a> https:\/\/t.co\/SPkgba1cL2<\/a><\/p>\n

\u2014 McMaster Health Sciences (@machealthsci) April 15, 2024<\/a><\/p><\/blockquote>\n